Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$1.85B |
| 2 |
Marvell Technology
MRVL
|
+$1.57B |
| 3 |
Adobe
ADBE
|
+$1.52B |
| 4 |
Celanese
CE
|
+$1.08B |
| 5 |
Cenovus Energy
CVE
|
+$858M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.97B |
| 2 |
Broadcom
AVGO
|
+$1.4B |
| 3 |
D.R. Horton
DHI
|
+$1.26B |
| 4 |
Micron Technology
MU
|
+$1.24B |
| 5 |
GE Aerospace
GE
|
+$1.19B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.09% |
| 2 | Healthcare | 15.85% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Industrials | 11.99% |
| 5 | Communication Services | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Alcon
ALC
$35.6B
| $4.48M | ﹤0.01% |
+53,905
| New | +$4.12M |
|
402
Ares Management
ARES
$32.1B
| $4.4M | ﹤0.01% |
45,670
| – | – |
|
403
CEVA Inc
CEVA
$857M
| $4.32M | ﹤0.01% |
169,233
-5,767
| -3% | -$145K |
|
404
Sony
SONY
$138B
| $4.27M | ﹤0.01% |
237,095
+2,110
| +0.9% | +$39.6K |
|
405
ASML
ASML
$695B
| $4.03M | ﹤0.01% |
5,577
+117
| +2% | +$79.5K |
|
|
NVO
406
Novo Nordisk
NVO
$203B
| $2.55M | ﹤0.01% |
32,534
+506
| +2% | +$41.3K |
|
|
SCHW
407
Charles Schwab
SCHW
$189B
| $2.54M | ﹤0.01% |
44,766
| – | – |
|
408
Woodside Energy
WDS
$43.6B
| $2.05M | ﹤0.01% |
89,438
+2,073
| +2% | +$47.5K |
|
409
ING
ING
$102B
| $1.72M | ﹤0.01% |
129,714
+1,497
| +1% | +$19.1K |
|
410
TotalEnergies
TTE
$194B
| $1.69M | ﹤0.01% |
29,689
+349
| +1% | +$21.1K |
|
411
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $433K | ﹤0.01% |
988
+115
| +13% | +$48.3K |
|
412
iShares MSCI ACWI ETF
ACWI
$33.4B
| $373K | ﹤0.01% |
3,927
-2,071
| -35% | -$192K |
|
413
Rio Tinto
RIO
$165B
| $232K | ﹤0.01% |
3,639
+7
| +0.2% | +$450 |
|
414
Applied Materials
AMAT
$435B
| – | – |
-7,419,646
| Closed | -$911M |
|
415
Ametek
AME
$59.3B
| – | – |
-325,759
| Closed | -$47.3M |
|
|
AZUL
416
DELISTED
Azul
AZUL
| – | – |
-7,570,322
| Closed | -$54.1M |
|
417
Beam Therapeutics
BEAM
$2.76B
| – | – |
-491,882
| Closed | -$15.1M |
|
418
Cable One
CABO
$191M
| – | – |
-26,531
| Closed | -$18.6M |
|
419
Cullen/Frost Bankers
CFR
$10.4B
| – | – |
-277,221
| Closed | -$29.2M |
|
420
Chegg
CHGG
$88.9M
| – | – |
-6,609,811
| Closed | -$108M |
|
421
FIVE9
FIVN
$2.33B
| – | – |
-156,380
| Closed | -$11.3M |
|
422
Graham Holdings Company
GHC
$5.03B
| – | – |
-25,000
| Closed | -$14.9M |
|
423
Health Catalyst
HCAT
$135M
| – | – |
-568,785
| Closed | -$6.64M |
|
424
Huazhu Hotels Group
HTHT
$12.7B
| – | – |
-784,872
| Closed | -$38.4M |
|
425
Lam Research
LRCX
$408B
| – | – |
-901,290
| Closed | -$47.8M |
|
Similar funds
Capital Research Global Investors's Q2 2023 Portfolio in Review
As of Q2 2023, Capital Research Global Investors held 446 positions worth $373B, up 6.5% from $350B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital Research Global Investors's Q2 2023 filing shows 22 new, 206 increased, 135 reduced and 32 closed positions. Its largest new stake was Capital One: 7,999,882 shares worth $875M. The largest sale was Meta Platforms (Facebook), an estimated $1.97B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q2 2023 buy was Capital One: 7,999,882 shares worth $875M.
- Capital Research Global Investors added most to Texas Instruments in Q2 2023, an estimated $1.85B increase.
- Capital Research Global Investors's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.97B.
- Capital Research Global Investors fully exited Applied Materials in Q2 2023, selling an estimated $911M.
- Capital Research Global Investors's ten largest holdings make up 29% of its $373B portfolio in Q2 2023.
- Capital Research Global Investors opened 22 new positions and closed 32 in Q2 2023.
- Capital Research Global Investors's portfolio value rose 6.5% quarter-over-quarter to $373B.
Based on Capital Research Global Investors's 13F filing for Q2 2023, filed 11 Aug 2023.